Hangzhou Tigermed Consulting Co., Ltd
300347
Kedudukan dalam Saham
#3216
Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides... Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People’s Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
Harga Saham
$7.44
Modal Pasaran
$5.49B
Perubahan (1 hari)
-2.99%
Perubahan (1 tahun)
-0.42%
Negara
CN
Perdagangan Hangzhou Tigermed Consulting Co., Ltd (300347)
Kategori
Healthcare
Sejarah pecahan saham untuk Hangzhou Tigermed Consulting Co., Ltd (300347)
Saham Hangzhou Tigermed Consulting Co., Ltd (simbol: 300347) telah mengalami sejumlah 4 pecahan saham.
Pecahan saham terkini berlaku pada Jul 01, 2019.
Satu saham 300347 yang dibeli sebelum May 02, 2013 kini bersamaan dengan 12 saham 300347.
Pecahan saham terkini berlaku pada Jul 01, 2019.
Satu saham 300347 yang dibeli sebelum May 02, 2013 kini bersamaan dengan 12 saham 300347.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| 2019-07-01 | 3:2 | x1.5 | x12 |
| 2015-05-20 | 2:1 | x2 | x8 |
| 2014-04-22 | 2:1 | x2 | x4 |
| 2013-05-02 | 2:1 | x2 | x2 |
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 1 | x100 |
BE
|
|
| 0 | - |
NL
|
